Update October 2025: Smart Reporting has since rebranded to Jacobian.
Smart Reporting automates and optimizes workflows in medical documentation, relieving physicians and generating valuable data at the same time. For this purpose, the Munich startup has developed voice-controlled AI-powered reporting software for radiology, pathology, and other clinical fields. With it, fully evaluable and machine-readable reports are created. In doing so, the Munich-based company contributes to the digitization of healthcare by automating previously manual processes. Additionally, data collected in hospitals is made usable for later evaluation, such as for medical research. For distribution, the startup, founded in 2014 as a spinoff of LMU, relies on large international healthcare IT partnerships, including with Siemens Healthineers, GE Healthcare, and Canon.
Now Smart Reporting has successfully raised 23 million euros – bringing the startup’s total financing to over 50 million euros. The lead investor in the now-completed Series C is TVM Capital Life Sciences from Canada. Bayern Kapital with the Scaleup Fund Bavaria and existing investors also supported the round. The new funds are intended primarily for expanding international partnerships and product development. In addition, expanding market presence in the USA, Canada, Australia, and New Zealand is a key focus. To strengthen its presence in international markets, Smart Reporting also recently entered into a deeper partnership with Solventum (formerly 3M Health Information Systems). The company is considered one of the market leaders in radiological reporting in North America.
Hubert Birner, Managing Partner at TVM Capital Life Science, explains:
“New technologies such as artificial intelligence and machine learning are one of the drivers of innovation in the healthcare industry and offer significant growth potential. TVM sees Smart Reporting, whose leading technology is already used by thousands of physicians around the world, as a future international market leader in the fields of radiology and pathology. TVM was also convinced by the focus on industry partnerships in distribution.”
“TVM sees Smart Reporting as a future international market leader”
Stefan Fischer, Managing Partner at TVM Capital Life Sciences, adds:
“As an international life sciences venture capital investor, TVM finances medical technologies and innovative healthtech in addition to classic drug development. Here, differentiated business models of companies that are already commercial and create immediate benefit for patients with their technology are in focus. Smart Reporting fits perfectly into this investment strategy.”
And Wieland Sommer, founder and CEO of Smart Reporting, adds:
“We are very pleased with the successful financing round and thank TVM and our other investors for their strong support. With the additional capital, we will be able to consistently continue our international growth strategy, which we recently launched with our market entry into the USA. Our focus in the coming months will be on penetrating global healthcare IT key markets and further developing AI-based solutions.”
Monika Steger, Managing Director of Bayern Kapital, points to Smart Reporting’s potential:
“Healthcare systems worldwide face the same challenge: they want to ensure high-quality healthcare and physician availability while keeping costs as low as possible. Given demographic change and increasing global life expectancy, this is no easy task. We are convinced: technology-based, scalable solutions like SmartReports will be a crucial building block in tackling this challenge in the future. That is why we see great growth potential in Smart Reporting as a pioneer of digital medical reporting and are pleased to support the company in its expansion plans.”
